Resilient and flexible biopharmaceutical supply networks: strengthening the vaccine supply chain through a manufacturing supply chain data exchange

“...the vast majority of manufacturers of all types still rely on emails, faxes, and phone calls to exchange critical data from their suppliers, often resulting in delays and inefficiencies.”

The COVID-19 pandemic exposed important flaws in the inbound supply chain for vaccines. NIIMBL and CESMII are working with key stakeholders to develop a means for vaccine manufacturers and suppliers to share information securely for improved supply chain tracking, resilience, and optimization.

Please enter your email to access content Read now